デジタルPCRの市場規模、シェア、成長分析；タイプ別、製品別、技術別、適応症別、用途別、エンドユーザー別、地域別 - 産業予測 2025～2032年

デジタルPCR市場規模は2023年に83億米ドルと評価され、2024年の90億9,000万米ドルから2032年には187億8,000万米ドルに成長し、予測期間（2025～2032年）のCAGRは9.5%で成長する見通しです。

世界のデジタルPCR（ポリメラーゼ連鎖反応）市場は、精密な核酸定量・分析に対する需要の高まりに後押しされ、大きな成長を遂げています。独自の感度と精度を持つデジタルPCRは、研究、疾病診断、遺伝子検査に不可欠であり、専門家が信頼性の高い結果を得ることで、患者の治療を向上させ、科学の進歩を促進します。市場促進要因としては、感染症や遺伝性疾患の増加、個別化治療の推進、ゲノム研究の進歩などが挙げられます。しかし、装置コストの高さや認知度の低さといった課題も依然として残っています。特筆すべき最近の動向としては、同時標的検出のためのマルチプレックスデジタルPCRアッセイの出現や、デジタルPCRと次世代シーケンサーとの統合が挙げられます。さらに、新興国市場での採用拡大や革新的な製品の発売が市場成長を後押ししています。

目次

イントロダクション

• 調査の目的
• 調査範囲
• 定義

調査手法

• 情報調達
• 二次と一次データの方法
• 市場規模予測
• 市場の前提条件と制限

エグゼクティブサマリー

• 世界市場の見通し
• 供給と需要の動向分析
• セグメント別機会分析

市場力学と見通し

• 市場概要
• 市場規模
• 市場力学
  • 促進要因と機会
  • 抑制要因と課題
• ポーターの分析

主な市場の考察

• 重要成功要因
• 競合の程度
• 主な投資機会
• 市場エコシステム
• 市場の魅力指数（2024年）
• PESTEL分析
• マクロ経済指標
• バリューチェーン分析
• 価格分析
• 技術分析

デジタルPCR市場規模：タイプ別

• 市場概要
• 定量的型
• デジタル型
• エンドポイント型

デジタルPCR市場規模：製品別

• 市場概要
• 消耗品と試薬
• デジタルPCR楽器
• ソフトウェアとサービス

デジタルPCR市場規模：技術別

• 市場概要
• ドロップレットデジタルPCR
• チップベースデジタルPCR
• その他

デジタルPCR市場規模：適応症別

• 市場概要
• 腫瘍学
• 感染症
• 遺伝性疾患
• その他

デジタルPCR市場規模：用途別

• 市場概要
• 臨床応用
• 調査アプリケーション
• 法医学アプリケーション
• 環境アプリケーション
• その他の用途

デジタルPCR市場規模：エンドユーザー別

• 市場概要
• 病院および診断検査室
• 学術研究機関
• 製薬およびバイオテクノロジー企業
• CROとCDMO
• 法医学研究所
• その他のエンドユーザー

デジタルPCR市場規模

• 北米
  • 米国
  • カナダ
• 欧州
  • ドイツ
  • スペイン
  • フランス
  • 英国
  • イタリア
  • その他欧州地域
• アジア太平洋地域
  • 中国
  • インド
  • 日本
  • 韓国
  • その他アジア太平洋地域
• ラテンアメリカ
  • ブラジル
  • その他ラテンアメリカ地域
• 中東・アフリカ
  • GCC諸国
  • 南アフリカ
  • その他中東・アフリカ

競合情報

• 上位5社の比較
• 主要企業の市場ポジショニング（2024年）
• 主な市場企業が採用した戦略
• 最近の市場動向
• 企業の市場シェア分析（2024年）
• 主要企業の企業プロファイル
  • 企業の詳細
  • 製品ポートフォリオ分析
  • 企業のセグメント別シェア分析
  • 収益の前年比比較（2022～2024年）

主要企業プロファイル

• Bio-Rad Laboratories, Inc.（USA）
• Thermo Fisher Scientific Inc.（USA）
• QIAGEN N.V.（Germany/Netherlands）
• F. Hoffmann-La Roche AG（Switzerland）
• Merck KGaA（Germany）
• Danaher Corporation（USA）
• Sysmex Corporation（Japan）
• JN Medsys Pte. Ltd.（Singapore）
• Stilla Technologies SAS（France）
• Standard BioTools Inc.（USA）
• Fluidigm Corporation（USA）
• Avance Biosciences（USA）
• Takara Bio Inc.（Japan）
• Meridian Bioscience（USA）
• Becton, Dickinson and Company（USA）
• Abbott Laboratories（USA）
• Promega Corporation（USA）
• Endress+Hauser Group Services AG（Switzerland）
• Biomerieux（France）
• Eppendorf AG（Germany）

結論と提言

Digital PCR Market size was valued at USD 8.3 billion in 2023 and is poised to grow from USD 9.09 billion in 2024 to USD 18.78 billion by 2032, growing at a CAGR of 9.5% during the forecast period (2025-2032).

The global digital PCR (Polymerase Chain Reaction) market is experiencing significant growth, fueled by the rising demand for precise nucleic acid quantification and analysis. Its unique sensitivity and accuracy make digital PCR vital for research, disease diagnosis, and genetic testing, empowering professionals to achieve reliable results that enhance patient care and facilitate scientific advancements. Key market drivers include the increasing prevalence of infectious diseases and genetic disorders, the push for personalized therapies, and advancements in genomic research. However, challenges such as high instrument costs and limited awareness persist. Noteworthy recent trends include the emergence of multiplex digital PCR assays for simultaneous target detection and the integration of digital PCR with next-generation sequencing. Additionally, the growing adoption in developing regions and innovative product launches are propelling market growth.

Top-down and bottom-up approaches were used to estimate and validate the size of the Digital Pcr market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Digital Pcr Market Segments Analysis

Global Digital PCR Market is segmented by Type, Product, Technology, Indication, Application, End User and region. Based on Type, the market is segmented into Quantitative, Digital and End-point. Based on Product, the market is segmented into Consumables & Reagents, Digital PCR Instruments and Software & Services. Based on Technology, the market is segmented into Droplet Digital PCR, Chip-based Digital PCR and Others. Based on Indication, the market is segmented into Oncology, Infectious Disease, Genetic Disorders and Others. Based on Application, the market is segmented into Clinical Applications, Research Applications, Forensic Applications, Environmental Applications and Other Applications. Based on End User, the market is segmented into Hospitals and Diagnostic Laboratories, Academic and Research Institutes, Pharmaceutical and Biotechnology Companies, CROs and CDMOs, Forensic Laboratories and Other End Users. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Digital Pcr Market

The digital PCR market is significantly driven by the rising demand for precise diagnostic tools within the healthcare sector. As the industry increasingly embraces precision medicine, there is a heightened need for testing methods that offer high sensitivity and specificity. Digital PCR technology plays a crucial role in clinical diagnostics and research by proficiently detecting genetic alterations, cancer biomarkers, and infectious diseases. The emphasis on quality diagnostics is pivotal in customizing therapies tailored to individual patient needs, further fueling the demand for personalized treatment approaches. This growing requirement for superior diagnostic accuracy is propelling substantial growth in the digital PCR market.

Restraints in the Digital Pcr Market

The digital PCR market faces significant challenges primarily due to the high costs associated with essential equipment and consumables, which pose a substantial barrier, especially for smaller laboratories in developing nations. The financial investment required for the necessary apparatus and reagents can deter access to advanced diagnostic technologies. As a result, many healthcare providers might lean towards more affordable traditional PCR methods, hindering the widespread adoption and integration of digital PCR solutions. This financial constraint ultimately limits the market's growth potential, as the disparity in access can stifle innovation and prevent smaller labs from fully embracing the benefits of digital PCR technology.

Market Trends of the Digital Pcr Market

The digital PCR market is currently experiencing a significant trend marked by the integration of machine learning (ML) and artificial intelligence (AI). This advancement enhances data processing capabilities, allowing for more accurate analysis of complex genetic information. AI algorithms streamline workflows by automating routine tasks and refining experimental designs, ultimately boosting productivity. Furthermore, machine learning facilitates improved modeling, leading to deeper insights into genetic variants and the underlying causes of diseases. As a result, there is a growing demand for sophisticated diagnostic tools across various sectors, which is concurrently increasing the usability and appeal of digital PCR devices, positioning the market for robust growth.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Technology Analysis

Global Digital PCR Market Size by Type & CAGR (2025-2032)

• Market Overview
• Quantitative
• Digital
• End-point

Global Digital PCR Market Size by Product & CAGR (2025-2032)

• Market Overview
• Consumables & Reagents
• Digital PCR Instruments
• Software & Services

Global Digital PCR Market Size by Technology & CAGR (2025-2032)

• Market Overview
• Droplet Digital PCR
• Chip-based Digital PCR
• Others

Global Digital PCR Market Size by Indication & CAGR (2025-2032)

• Market Overview
• Oncology
• Infectious Disease
• Genetic Disorders
• Others

Global Digital PCR Market Size by Application & CAGR (2025-2032)

• Market Overview
• Clinical Applications
• Research Applications
• Forensic Applications
• Environmental Applications
• Other Applications

Global Digital PCR Market Size by End User & CAGR (2025-2032)

• Market Overview
• Hospitals and Diagnostic Laboratories
• Academic and Research Institutes
• Pharmaceutical and Biotechnology Companies
• CROs and CDMOs
• Forensic Laboratories
• Other End Users

Global Digital PCR Market Size & CAGR (2025-2032)

• North America (Type, Product, Technology, Indication, Application, End User)
  • US
  • Canada
• Europe (Type, Product, Technology, Indication, Application, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Type, Product, Technology, Indication, Application, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Type, Product, Technology, Indication, Application, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Type, Product, Technology, Indication, Application, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Bio-Rad Laboratories, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Thermo Fisher Scientific Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• QIAGEN N.V. (Germany/Netherlands)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• F. Hoffmann-La Roche AG (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck KGaA (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Danaher Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sysmex Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• JN Medsys Pte. Ltd. (Singapore)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Stilla Technologies SAS (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Standard BioTools Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Fluidigm Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Avance Biosciences (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Takara Bio Inc. (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Meridian Bioscience (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Becton, Dickinson and Company (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abbott Laboratories (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Promega Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Endress+Hauser Group Services AG (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Biomerieux (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Eppendorf AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations